Search Results 501-510 of 18161 for peptide therapy
Key secondary endpoints are toxicity, end-Induction response, and overall survival. Late effects of therapy including targeted therapies will be compared with ...
... therapy," says S. Vincent Rajkumar, M.D., a Mayo Clinic hematologist and senior author of the trial. "We found that treatment of smoldering myeloma delays ...
Concurrently, the treatment of active thyroid eye disease (TED) has historically relied on systemic corticosteroids, which offer limited relief for structural ...
"This could revolutionize the treatment of osteoarthritis," says Dr. Evans, who directs the Musculoskeletal Gene Therapy Research lab at Mayo Clinic. In ...
... therapy with metformin and sulphonylurea will have an HbA1c of ≤ 10.% ... Diabetics on insulin, glucagon-like peptide-1 based therapies or thiazolidinediones ...
... therapy as an outpatient for COVID-19 infection. Also, to evaluate the proportion of patients who discontinued Paxlovid therapy prematurely due to dysgeusia.
... treatment of patients with biopsy-proven high grade glioma prior to conventional therapy. Safety is defined as any acute grade 3 (CTCAE v5.0) or greater ...
... treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!